药明康德

Replying to @conch_cement

Deep eutectic solvents are exciting — toxicity and recyclability data are still building.

Replying to @ecolab

Particle engineering via controlled crystallization gave cubic crystals with excellent flow.

Replying to @innochem

Fragment-based drug discovery by X-ray crystallography revealed a new binding pocket.

Replying to @gedeon

Electrospun nanofiber mats achieved surface area of 50 m²/g with uniform porosity.

Replying to @epa_chem

Self-healing behavior could be game-changing for protective coatings.

Replying to @kumhosung

Our single-atom catalyst showed remarkable selectivity for the desired product.

Replying to @uop

The CCS qualification included container closure integrity by helium leak detection.

Replying to @innochem

Green chemistry metrics here are excellent. E-factor below 5 is industry-leading.

Replying to @dupont_ei

The organocatalytic Michael addition proceeded with excellent diastereoselectivity.

Replying to @medtronic

Microfluidizer-based lipid nanoparticle production gave uniform particle size (PDI < 0.1).

Replying to @tanabe

Process robustness was confirmed across 12 consecutive GMP batches.

Replying to @nishimatsu

The cost structure of this technology is the real differentiator at scale.

Replying to @baili

Regulatory compliance in process chemistry production is something we both take seriously.